FindTrial
Sign In

usefulness of IPL in treating melasma

Evaluation of efficacy and safety profile of intense pulse light treatment in melasma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009529
Enrollment
30
Registered
2017-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with Melasma

Interventions

Intervention1: Intense Pulse Light: Intense Pulse Light(IPL)device will be used to treat melasma. a total of six sessions will be given to patient. Intervention2: Intense pulse light (IPL): ipl system

Sponsors

IPGMER and SSKM HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.cases of melasma attending OPD consenting to participate in study through written informed consent. 2.patient above 18 years of age

Exclusion criteria

Exclusion criteria: 1.patient unable or unwilling to give consent. 2.patient with unrealistic expectation. 3.patient with active infection,SLE,pregnancy or on photosensitive mediacation. 4.patient on other form of treatment for melasma.

Design outcomes

Primary

MeasureTime frame
improvement of melasma assessed by clinician global index.Timepoint: 12 months—

Secondary

MeasureTime frame
skin rejuvinationTimepoint: 12 months—

Countries

India

Contacts

Public ContactAbhishek De

Institute of Post Graduate Medical Education and Research

dr_abhishek_de@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026